Percutaneous radiofrequency ablation of colorectal cancer liver metastases: Factors affecting outcomes-a 10-year experience at a single center

Radiology

Volumn 278, Issue 2, 2016, Pages 601-611

  Shady, Waleed ^a   Petre, Elena N ^a   Gonen, Mithat ^a   Erinjeri, Joseph P ^a   Brown, Karen T ^a   Covey, Anne M ^a   Alago, William ^a   Durack, Jeremy C ^a   Maybody, Majid ^a   Brody, Lynn A ^a   Siegelbaum, Robert H ^a   D'Angelica, Michael I ^a   Jarnagin, William R ^a   Solomon, Stephen B ^a   Kemeny, Nancy E ^a   Sofocleous, Constantinos T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; CONTRAST MEDIUM;

ADULT; ARTICLE; BACTEREMIA; BILOMA; BLADDER CATHETERIZATION; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; COLORECTAL CANCER; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRYOABLATION; ELECTROPORATION; FEMALE; HUMAN; LIVER HEMATOMA; LIVER METASTASIS; LIVER RESECTION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MICROWAVE THERAPY; ONCOLOGICAL PARAMETERS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PLEURA EFFUSION; PNEUMOTHORAX; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; TUMOR VOLUME; URINE RETENTION; VEIN THROMBOSIS; AGED; CATHETER ABLATION; COLORECTAL TUMOR; INTERVENTIONAL MAGNETIC RESONANCE IMAGING; INTERVENTIONAL RADIOLOGY; LIVER NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; SURVIVAL RATE; X-RAY COMPUTED TOMOGRAPHY;

AGED; CATHETER ABLATION; COLORECTAL NEOPLASMS; CONTRAST MEDIA; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING, INTERVENTIONAL; MALE; PROGNOSIS; RADIOGRAPHY, INTERVENTIONAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84955600763     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2015142489     Document Type: Article

References (34)

1. Ruers T, Bleichrodt RP. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 2002;38(7):1023-1033.
2. Norstein J, Silen W. Natural history of liver metastases from colorectal carcinoma. J Gastrointest Surg 1997;1(5):398-407.
3. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 1996;77(7):1254-1262.
4. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230(3):309-318; discussion 318-321.
5. Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 2004;239(6):818-825; discussion 825-827.
6. Bengmark S, Hafström L. The natural history of primary and secondary malignant tumors of the liver. I. The prognosis for patients with hepatic metastases from colonic and rectal carcinoma by laparotomy. Cancer 1969;23(1):198-202.
7. Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004;350(23):2335-2342.
8. Van Cutsem E, Köhne CH, Hitre E, et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009;360(14):1408-1417.
9. Elias D, De Baere T, Smayra T, Ouellet JF, Roche A, Lasser P. Percutaneous radiofrequency thermoablation as an alternative to surgery for treatment of liver tumour recurrence after hepatectomy. Br J Surg 2002; 89(6):752-756.
10. Sofocleous CT, Petre EN, Gonen M, et al. CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy. J Vasc Interv Radiol 2011;22(6):755-761.
11. Benson AB 3rd, Bekaii-Saab T, Chan E, et al. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw 2013;11(2):141-152; quiz 152.
12. Livraghi T, Solbiati L, Meloni F, Ierace T, Goldberg SN, Gazelle GS. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: The "testof-time approach". Cancer 2003;97(12): 3027-3035.
13. Solbiati L, Ahmed M, Cova L, Ierace T, Brioschi M, Goldberg SN. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up. Radiology 2012;265(3): 958-968.
14. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003;226(2):441-451.
15. Hamada A, Yamakado K, Nakatsuka A, et al. Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates. Jpn J Radiol 2012; 30(7):567-574.
16. Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol 2009;19(5):1206-1213.
17. Van Tilborg AA, Meijerink MR, Sietses C, et al. Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: A potentially curative intervention. Br J Radiol 2011;84(1002):556-565.
18. Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol 2010;28(3):493-508.
19. Guenette JP, Dupuy DE. Radiofrequency ablation of colorectal hepatic metastases. J Surg Oncol 2010;102(8):978-987.
20. Wang X, Sofocleous CT, Erinjeri JP, et al. Margin size is an independent predictor of local tumor progression after ablation of colon cancer liver metastases. Cardiovasc Intervent Radiol 2013;36(1):166-175.
21. Sofocleous CT, Garg S, Petrovic LM, et al. Ki-67 is a prognostic biomarker of survival after radiofrequency ablation of liver malignancies. Ann Surg Oncol 2012;19(13):4262-4269.
22. Ryan ER, Sofocleous CT, Schöder H, et al. Split-dose technique for FDG PET/CT-guided percutaneous ablation: A method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness. Radiology 2013;268(1):288-295.
23. Goldberg SN, Grassi CJ, Cardella JF, et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005;235(3):728-739.
24. Ahmed M, Solbiati L, Brace CL, et al. Imageguided tumor ablation: standardization of terminology and reporting criteria-a 10-year update. Radiology 2014;273(1):241-260.
25. Pua BB, Sofocleous CT. Imaging to optimize liver tumor ablation. Imaging Med 2010;2(4): 433-443.
26. Burke DR, Lewis CA, Cardella JF, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography and biliary drainage. J Vasc Interv Radiol 2003;14(9 Pt 2): S243-S246.
27. Ito H, Are C, Gonen M, et al. Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008;247(6):994-1002.
28. Petre EN, Jia X, Thornton RH, et al. Treatment of pulmonary colorectal metastases by radiofrequency ablation. Clin Colorectal Cancer 2013;12(1):37-44.
29. Pulitanò C, Bodingbauer M, Aldrighetti L, et al. Liver resection for colorectal metastases in presence of extrahepatic disease: results from an international multi-institutional analysis. Ann Surg Oncol 2011;18(5):1380-1388.
30. Nuzzo G, Giuliante F, Ardito F, et al. Influence of surgical margin on type of recurrence after liver resection for colorectal metastases: A single-center experience. Surgery 2008;143(3):384-393.
31. Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007;25(29):4575-4580.
32. Sofocleous CT, Klein KM, Hubbi B, et al. Histopathologic evaluation of tissue extracted on the radiofrequency probe after ablation of liver tumors: preliminary findings. AJR Am J Roentgenol 2004;183(1):209-213.
33. Snoeren N, Huiskens J, Rijken AM, et al. Viable tumor tissue adherent to needle applicators after local ablation: A risk factor for local tumor progression. Ann Surg Oncol 2011;18(13):3702-3710.
34. Sofocleous CT, Nascimento RG, Petrovic LM, et al. Histopathologic and immunohistochemical features of tissue adherent to multitined electrodes after RF ablation of liver malignancies can help predict local tumor progression: initial results. Radiology 2008;249(1):364-374.